Ambit, Inc. Press Releases

Published on September 25, 2023 - 15:39 GMT

Ambit Wins Global Genes’ RARE-X Xcelerate RARE Open Science Data Challenge 

MORRISTOWN, NEW JERSEY, USA, September 25, 2023 /⁨EINPresswire.com⁩/ -- Ambit Inc., a leading integrated biopharma solutions firm, proudly announces that it has been named a winner in the Xcelerate RARE Open Science Data Challenge, hosted by Global Genes…

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on September 19, 2023 - 13:00 GMT

Ambit Partners with Datavant to Drive Innovation in the Rare and Specialty Disease Markets 

MORRISTOWN, NEW JERSEY, USA, September 19, 2023 /⁨EINPresswire.com⁩/ -- Ambit, a leading integrated biopharma solutions firm specializing in the rare and specialty disease markets, is pleased to announce a partnership with Datavant, the leader in …

Distribution channels: Business & Economy, Companies ...

Published on September 7, 2023 - 13:00 GMT

Ambit Welcomes Dan McNamara as EVP of Commercial and Patient Strategy

MORRISTOWN, NEW JERSEY, USA, September 7, 2023 /⁨EINPresswire.com⁩/ -- Ambit, a technology-enabled solutions company dedicated to guiding biopharma clients through the intricate landscape of rare and specialty disease product development, proudly announces …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 11, 2023 - 16:00 GMT

Ambit Redefines Biopharma Solutions with Dynamic New Branding Approach

New branding emphasizes dedication and commitment to deliver best-in-class solutions for biopharma. MORRISTOWN, NEW JERSEY, USA, July 11, 2023 /⁨EINPresswire.com⁩/ -- Ambit RD, Inc., a leading integrated biopharma solutions firm, is pleased to announce …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...